索引超出了数组界限。
[ 1 ] Burton L, Tyson SF. Screening for cognitive impairment after stroke: a systematic review of psychometric properties and clinical utility[J]. J Rehabil Med, 2015, 47(3):193-203.
[ 2 ] Verhaegen P, Borchelt M, Smith J. Relation between cardiovascular and metabolic disease and cognition in very old age: cross-sectional and longitudinal findings from the berlin aging study[J]. Health Psychol, 2003, 22(6):559-569.
[ 3 ] Lima LM, Carvalho Md, Ferreira CN, et al. Atheromatosis extent in coronary artery disease is not correlated with apolipoprotein-E polymorphism and its plasma levels, but associated with cognitive decline[J]. Curr Alzheimer Res, 2010, 7(6):556-563.
[ 4 ] Barekatain M, Askarpour H, Zahedian F, et al. The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairment[J]. J Res Med Sci, 2014, 19(8):739-745.
[ 5 ] Reitz C, Tang MX, Luchsinger J, et al. Relation of plasma lipids to alzheimer disease and vascular dementia[J]. Arch Neurol, 2004, 61(5):705-714.
[ 6 ] Stellos K, Katsiki N, Tatsidou P, et al. Association of platelet activation with vascular cognitive impairment: implications in dementia development?[J]. Curr Vasc Pharmacol, 2014, 12(1):152-154.
[ 7 ] Toyama K, Sugiyama S, Oka H, et al. A pilot study: the beneficial effects of combined statinexercise therapy on cognitive function in patients with coronary artery disease and mild cognitive decline[J]. Intern Med, 2017, 56(6):641-649.
[ 8 ] Suraweera C, de Silva V, Hanwella R, et al. Simvastatin-induced cognitive dysfunction: two case reports[J]. J Med Case Rep, 2016, 10:83.
[ 9 ] Zuccalà G, Cattel C, Manes-Gravina E, et al. Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure[J]. J Neurol Neurosurg Psychiatry, 1997, 63(4):509-512.
[10] Choi BR, Kim JS, Yang YJ, et al. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy[J]. Am J Cardiol, 2006, 97(9):1365-1369.
[11] Vogels RL, Oosterman JM, Van Harten B, et al. Neuroimaging and correlates of cognitive function among patients with heart failure[J]. Dement Geriatr Cogn Disord, 2007, 24(6):418-423.
[12] Huynh Q, Negishi K, Marwick TH. Is atrial or ventricular dysfunction a contributor to cognitive impairment in heart failure patients?[J] Eur Heart J, 38(suppl 1):ehx501.
[13] Hay M, Vanderah TW, Samareh-Jahani F, et al. Cognitive impairment in heart failure: a protective role for(1-7)[J]. Behav Neurosci, 2017, 131(1):99-114.
[14] Shaukat A, Habib A, Lane KA, et al. Anticholinergic medications: an additional contributor to cognitive impairment in the heart failure population?[J]. Drugs Aging, 2014, 31(10):749-754.
[15] Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial[J]. JACC Heart Fail, 2014, 2(6):641-649.
[16] Vogels RL, Oosterman JM, van Harten B, et al. Profile of cognitive impairment in chronic heart failure[J]. J Am Geriatr Soc, 2007, 55(11):1764-1770.
[17] Alosco ML, Spitznagel MB, van Dulmen M, et al. The additive effects of type-2 diabetes on cognitive function in older adults with heart failure[J]. Cardiol Res Pract, 2012, 2012:348054.
[18] Pulignano G, Del Sindaco D, Di Lenarda A, et al. Chronic renal dysfunction and anaemia are associated with cognitiveimpairmentin older patients with heart failure[J]. J Cardiovasc Med(Hagerstown), 2014, 15(6):481-490.
[19] Yang H, Niu W, Zang X, et al. The association between atrial fibrillation and cognitive function in patients with heart failure[J]. Eur J Cardiovasc Nurs, 2017, 16(2):104-112.
[20] Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies[J]. CMAJ, 2012, 184(6):E329-E336.
[21] Madhavan M, Graff-Radford J, Piccini JP, et al. Cognitive dysfunction in atrial fibrillation[J]. Nat Rev Cardiol, 2018, 15(12):744-756.
[22] Efimova I, Efimova N, Chernov V, et al. Ablation and pacing: improving brain perfusion and cognitive function in patients with atrial fibrillation and uncontrolled ventricular rates[J]. Pacing Clin Electrophysiol, 2012, 35(3):320-326.
[23] Santangeli P, Di Biase L, Bai R, et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis[J]. Heart Rhythm, 2012, 9(11):1761-1768.
[24] Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4):230-243.
[25] Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline[J]. JAMA, 2004, 292(18):2237-2242.
[26] Knecht S, Oelschläger C, Duning T, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy[J]. Eur Heart J, 2008, 29(17):2125-2132.